Pathophysiological implications of insulin resistance on vascular endothelial function
The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Abstract
Background Insulin resistance is a key component of the insulin resistance syndrome and is a crucially important metabolic abnormality in Type 2 diabetes. Insulin‐resistant individuals are at significantly increased risk of cardiovascular disease, although the underlying mechanisms remain incompletely understood. The endothelium is thought to play a critical role in maintaining vascular homeostasis, a process dependent on the balance between the production of nitric oxide, superoxide and other vasoactive substances. Endothelial dysfunction has been demonstrated in insulin‐resistant states in animals and humans and may represent an important early event in the development of atherosclerosis. Insulin resistance may be linked to endothelial dysfunction by a number of mechanisms, including disturbances of subcellular signalling pathways common to both insulin action and nitric oxide production. Other potential unifying links include the roles of oxidant stress, endothelin, the renin angiotensin system and the secretion of hormones and cytokines by adipose tissue. Lifestyle measures and drug therapies which improve insulin sensitivity and ameliorate endothelial dysfunction may be important in delaying the progression to overt cardiovascular disease in at risk individuals. Methods We conducted a literature search using Medline, restricted to articles published in the English language between 1966 and the present, and reviewed bibliographies of relevant articles. An initial search strategy employing combinations of the MeSH terms: insulin resistance; endothelium, vascular; insulin; nitric oxide or hyperinsulinaemia produced over 300 references. Focused searches using keywords relevant to the molecular aspects of endothelial function and insulin signalling, and lifestyle or pharmacological interventions relevant to insulin resistance or endothelial function, produced over 300 further references. Abstracts of all references were screened before selecting those relevant to this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–227 of 227
Fulminant liver failure associated with flutamide therapy for hirsutism
Andrade, R. J., Lucena, M. I., Fernández‐Santaella, M. C., Suárez, F., Montero, J. L., Fraga, E., & Hidalgo, F. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00564-4 · Cited by 78
Donahue, R. P., Prineas, R. J., Donahue, R. A. D., Zimmet, P., Bean, J. A., de Courten, M., Collier, G. R., Goldberg, R. B., Skyler, J. S., & Schneiderman, N. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1092 · Cited by 77
Blüher, M., Kratzsch, J., & Paschke, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.328 · Cited by 75
Chisholm, D. J., Campbell, L. V., & Kraegen, E. W. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02132.x · Cited by 72
Potential Role of Bradykinin in Forearm Muscle Metabolism in Humans
Dietze, G. J., Wicklmayr, M., Rett, K., Jacob, S., & Henriksen, E. J. (1996) · Diabetes · doi:10.2337/diab.45.1.s110 · Cited by 63
Juan, C., Fang, V. S., Kwok, C., Perng, J. C., Chou, Y.-C., & Ho, L. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90105-1 · Cited by 59
Pro‐oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat
Laight, D. W., Desai, K. M., Gopaul, N. K., Änggård, E., & CARRIER, M. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702801 · Cited by 56
Kashiwagi, A., Shinozaki, K., Nishio, Y., Okamura, T., Toda, N., & Kikkawa, R. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00062-5 · Cited by 55
Endothelin Antagonism Uncovers Insulin-Mediated Vasorelaxation In Vitro and In Vivo
Verma, S., Yao, L., Stewart, D. J., Dumont, A. S., Anderson, T. J., & McNeill, J. H. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.328 · Cited by 55
Laight, D. W., Kengatharan, K. M., Gopaul, N. K., Änggård, E., & CARRIER, M. J. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702132 · Cited by 53
Lind, L., FUGMANN, A., Branth, S., Vessby, B. O., Millgård, J., Berne, C., & Lithell, H. (2000) · Clinical Science · doi:10.1042/cs0990169 · Cited by 51
Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation
Salvemini, D., Radziszewski, W., Mollace, V., Moore, A., Willoughby, D. A., & Vane, J. R. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90631-y · Cited by 51
Kearney, M. T., Cowley, A. J., Stubbs, T. A., Evans, A. J., & Macdonald, I. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00451-8 · Cited by 50
Self-citationReactivity of Mesenteric Arteries From Fructose Hypertensive Rats to Endothelin-1
Verma, S. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00107-6 · Cited by 48
PPAR agonists as direct modulators of the vessel wall in cardiovascular disease
Buchan, K. W., & Hassall, D. G. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200009)20:5<350::aid-med2>3.0.co;2-d · Cited by 40
Effects of inhibition of the renin‐angiotensin system on the cardiovascular actions of insulin
Katovich, M. J., & Pachori, A. S. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00044.x · Cited by 36
Petrie, J. R., Morris, A. D., Ueda, S., Small, M., Donnelly, R., Connell, J. M. C., & Elliott, H. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6599 · Cited by 35
Activation of the endothelin system in insulin resistance
Irving, J. (2001) · QJM · doi:10.1093/qjmed/94.6.321 · Cited by 35
Insulin resistance affects endothelium-dependent acetylcholine-induced coronary artery response
Inoue, T. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1872 · Cited by 32
Scheen, A. J., Letiexhe, M. R., & Lefèbvre, P. J. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00410.x · Cited by 30
Kearney, M. T., Cowley, A. J., Stubbs, T. A., & MacDonald, I. A. (1996) · Clinical Science · doi:10.1042/cs0910415 · Cited by 28
Self-citationWiggam, M. I., Hunter, S. J., Atkinson, A. B., Ennis, C. N., Henry, J. S., Browne, J. N., Sheridan, B., & Bell, P. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00012 · Cited by 28
Acute haemodynamic effects of lipolysis-induced increase of free fatty acids in healthy men
Kearney, M. T., Chowienczyk, P., Brett, S., Sutcliffe, A., Ritter, J. M., & Shah, A. M. (2002) · Clinical Science · doi:10.1042/cs1020495 · Cited by 27
Self-citationCirculating catecholamines and metabolic effects of captopril in NIDDM patients
Mattia, G. D., Ferri, C., Laurenti, O., Cassone-Faldetta, M., Piccoli, A., & Santucci, A. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.226 · Cited by 21
Insulin resistance in essential hypertension is related to plasma renin activity
Lind, L., Reneland, R., Andersson, P.-E., Haenni, A., & Lithell, H. (1998) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000642 · Cited by 18
Petrie, J. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1882 · Cited by 17
Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats
Naderali, E. K., Pickavance, L. C., Wilding, J. P. H., Doyle, P. J., & Williams, G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00866-4 · Cited by 11
Cited by
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
Insulin and neurodegenerative disease: shared and specific mechanisms
Craft, S., & Stennis Watson, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00681-7 · Cited by 830
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans
Vincent, H. K., & Taylor, A. G. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803177 · Cited by 736
Metadata
- Authors
- Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 20
- Issue
- 4
- Pages
- 255-268
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2164597948
- Cited by
- 306
- References
- 227
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.